FibroGen (FGEN) Tops Q4 EPS by 2c

February 27, 2018 4:28 PM EST

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $42.5 million versus the consensus estimate of $49.77 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings